scholarly article | Q13442814 |
editorial | Q871232 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.YGYNO.2019.08.016 |
P698 | PubMed publication ID | 31472939 |
P50 | author | Ginger J. Gardner | Q91946587 |
P2093 | author name string | Kara Long Roche | |
P2860 | cites work | Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 |
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center | Q30717971 | ||
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | Q35262997 | ||
Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol | Q39669919 | ||
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. | Q39902180 | ||
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer | Q40295814 | ||
Performance of AGO score for secondary cytoreduction in a high-volume U.S. center | Q40935735 | ||
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. | Q41721778 | ||
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer | Q44461877 | ||
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. | Q50000120 | ||
Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer | Q57903781 | ||
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma | Q60685709 | ||
Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial | Q61900008 | ||
Secondary cytoreduction for ovarian cancer following cisplatin therapy | Q70590731 | ||
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial | Q79158185 | ||
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer | Q90869406 | ||
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival? | Q91045719 | ||
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms | Q91967950 | ||
P433 | issue | 1 | |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 3-7 | |
P577 | publication date | 2019-08-29 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | State of the science: Evolving role of surgery for the treatment of ovarian cancer | |
P478 | volume | 155 |
Q96228870 | A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative | cites work | P2860 |
Search more.